DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (10)
2023
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615
2021
-
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
European urology oncology, Vol. 4, Núm. 3, pp. 464-472
-
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes
BJU International, Vol. 128, Núm. 2, pp. 196-205
2020
-
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet, Vol. 395, Núm. 10241, pp. 1907-1918
-
Survey of the impact of COVID-19 on oncologists' decision making in cancer
JCO Global Oncology, pp. 1248-1257
2018
2016
2014
-
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review
International Journal of Oncology, Vol. 44, Núm. 1, pp. 5-16